Intragenic Transcription from Defective HIV Proviruses Triggers Interferon Responses in Myeloid Cells

Defective HIV proviruses trigger chronic inflammation in people with HIV by producing aberrant intragenic RNAs from the *env* gene that activate the MDA5-MAVS innate immune pathway, leading to type I interferon responses in myeloid cells.

The Gist

The Big Picture: The "Ghost" in the Machine

Imagine your body is a high-tech fortress. When the HIV virus invades, it doesn't just attack; it sneaks into the fortress's blueprints (your DNA) and hides there. Even when you take medication (ART) that stops the virus from making new copies, these hidden blueprints remain.

For a long time, scientists thought the main problem was the "active" viruses that were still trying to replicate. But this paper reveals a new, sneaky culprit: Defective Proviruses.

Think of these defective proviruses as broken, half-written instructions left behind in the blueprint room. They are too broken to build a working virus (so they can't infect new cells), but they aren't completely silent either. They are like a broken radio that can't play music but is still buzzing with static.

The Problem: The "Buzzing" Causes Panic

The researchers discovered that these "broken radios" (defective proviruses) are actually spitting out strange, glitchy messages (RNA transcripts).

• The Analogy: Imagine a factory that is supposed to stop production. The main power switch is off (the virus is suppressed). However, a small, faulty generator inside the factory (a specific part of the virus called the env gene) is still humming. It's not making cars (viruses), but it is spewing out weird, incomplete parts.
• The Reaction: Your body's security guards (immune cells, specifically myeloid cells like macrophages) hear this buzzing. They think, "Something is wrong! We are under attack!" Even though there are no real enemies, the guards sound the alarm.

The Alarm System: MDA5 and MAVS

The paper identifies exactly how the body hears this buzzing.

1. The Sensor (MDA5): This is like a smoke detector in the factory. It is designed to spot strange, double-stranded smoke (the glitchy RNA).
2. The Siren (MAVS): Once the smoke detector spots the weird RNA, it pulls the fire alarm (MAVS).
3. The Firefighters (Interferons): The alarm triggers the release of "firefighters" (Type I Interferons and a chemical called IP-10). Their job is to fight the fire, but since there is no real fire, they just create a lot of smoke and noise.

The Result: This constant, low-level alarm system causes chronic inflammation. This is the "inflammaging" mentioned in the paper—the reason why people with HIV often get heart disease, brain fog, or age faster, even if their virus count is undetectable.

The Evidence: How They Proved It

The scientists didn't just guess; they ran a clever experiment to prove the "broken radio" theory:

1. The Clinical Clue: They looked at blood samples from real people with HIV. They found that the more "glitchy messages" (UTR-deficient RNA) a person had, the higher their levels of inflammatory chemicals (like IP-10 and TNF-alpha) were. It was a direct link.
2. The Lab Experiment (The "Silencing" Trick):
   • They took cells infected with HIV and used a molecular pair of scissors (CRISPR-Cas9) to cut out the main power switch (the 5' LTR) of the virus.
   • The Twist: Normally, cutting the main switch stops everything. But because of the "faulty generator" (the intragenic promoter in the env gene), the virus kept buzzing.
   • The Outcome: When they cut the main switch, the cells actually got more angry! They produced more inflammatory signals. Why? Because without the main switch, the "faulty generator" became the only thing running, and the immune system went into overdrive sensing these strange, capped, and tailed messages.

The Takeaway: Why This Matters

This paper changes the story of HIV.

• Old Story: "If we stop the virus from replicating, the patient is safe."
• New Story: "Even if the virus can't replicate, the broken pieces left behind are still causing trouble."

These defective proviruses are like ghosts in the machine. They aren't alive enough to kill you directly, but they are loud enough to keep your immune system stressed out 24/7.

The Solution?
Future treatments for HIV might need to do more than just stop the virus from copying itself. We might need to find a way to silence the broken radios (the defective proviruses) so they stop buzzing. If we can turn off that static, we might finally stop the chronic inflammation that causes heart disease and aging in people living with HIV.

Summary in One Sentence

Even when HIV is suppressed, "broken" copies of the virus left in your DNA act like a stuck alarm button, constantly tricking your immune system into fighting a war that isn't there, leading to long-term health problems.

Technical Summary

1. Problem Statement

Despite effective antiretroviral therapy (ART) that suppresses viral load to undetectable levels, People with HIV (PWH) suffer from chronic low-grade inflammation ("inflammaging") and age-associated comorbidities (e.g., cardiovascular disease, neurocognitive deficits).

• The Gap: While the latent HIV reservoir is known to contain transcriptionally repressed proviruses, the majority of these reservoir genomes are defective (containing mutations, deletions, or inversions that prevent virion production).
• The Hypothesis: The authors hypothesize that these defective proviruses are not silent. Instead, they undergo "spurious" intragenic transcription, generating aberrant RNAs that act as Pathogen-Associated Molecular Patterns (PAMPs). These RNAs are sensed by the host innate immune system, driving chronic inflammation and interferon (IFN) responses even in the absence of active viral replication.

2. Methodology

The study employed a multi-faceted approach combining clinical data analysis, CRISPR-Cas9 genome editing, and molecular biology techniques:

• Clinical Cohort Analysis:

  • Analyzed data from 22 PWH on suppressive ART (no detectable viremia).
  • Quantification: Used multiplex RT-droplet digital PCR (RT-ddPCR) to distinguish between:
    • UTR-containing RNAs: Transcripts initiating from the canonical 5' Long Terminal Repeat (LTR).
    • UTR-deficient RNAs: Transcripts initiating from an intragenic promoter within the env gene.
  • Correlation: Correlated RNA levels with serum cytokine levels (TNFα, IP-10, IL-6, IL-8, IL-12p70) measured via ELISA.

• In Vitro Engineering of Defective Proviruses:

  • Cell Models: Jurkat T-cell lines, THP-1 monocytes, and primary Monocyte-Derived Macrophages (MDMs).
  • CRISPR-Cas9 Strategy: Used Cas9 and specific gRNAs to delete the 5' LTR and the gag region of integrated HIV-1 proviruses. This rendered the provirus "defective" (unable to produce virions via the LTR) but left the intragenic env promoter intact.
  • Controls: Scrambled gRNA, intact provirus, and env-disrupted controls (NL4-3-dEnv-GFP).

• Mechanistic Characterization:

  • RNA Structure: Performed 5' cap pulldown assays using eIF4E-GFP conjugates and polyadenylation checks (polydT primers) to determine if intragenic transcripts possessed mRNA-like features (5' cap and 3' poly-A tail).
  • Pathway Dissection: Utilized THP-1 cell lines with stable knockdowns of MDA5 (a cytosolic RNA sensor) and MAVS (the downstream signaling adaptor) to test dependency of the immune response.
  • Readouts: Measured Type I Interferon (IFN) activity using HEK-293-ISRE-Luciferase reporter assays and quantified IP-10 (CXCL10) mRNA/protein levels.

3. Key Results

• Clinical Correlation:

  • Levels of UTR-deficient RNAs (intragenic transcripts) in PBMCs showed a significant positive correlation with serum levels of pro-inflammatory cytokines IP-10, TNFα, and IL-8.
  • Total HIV RNA or UTR-containing (canonical) RNA did not show strong correlations with these cytokines, suggesting the specific intragenic transcripts are the drivers.

• Defective Proviruses Drive Inflammation In Vitro:

  • CRISPR-mediated deletion of the 5' LTR in infected cells (creating defective proviruses) resulted in a 3-fold increase in Type I IFN activity in Jurkat cells.
  • In primary MDMs, defective proviruses induced a massive 75–1,000-fold increase in IP-10 mRNA and a 3–4-fold increase in IP-10 protein compared to controls.
  • Controls targeting endogenous genes (hprt) or scrambled guides did not induce this response, confirming the effect is specific to the defective HIV genome.

• Nature of the RNA:

  • Intragenic transcripts generated from defective proviruses were confirmed to be 5' capped (bound by eIF4E) and polyadenylated. This indicates they are processed like host mRNAs, making them potent triggers for cytosolic sensors.

• MDA5-MAVS Dependency:

  • Knockdown of MDA5 or MAVS in THP-1 cells completely abrogated the induction of IP-10 in response to defective proviruses.
  • This confirms that the innate immune system senses these aberrant RNAs via the MDA5-MAVS signaling cascade, a pathway typically associated with detecting double-stranded RNA.

4. Key Contributions

• Identification of a Specific Driver: The study identifies intragenic transcription from defective proviruses (specifically from the env promoter) as a distinct and potent driver of chronic inflammation in PWH on ART, separate from active viral replication.
• Mechanistic Link: It establishes a direct causal link between defective proviruses and Type I Interferon responses via the MDA5-MAVS pathway.
• RNA Characteristics: It demonstrates that these "aberrant" viral RNAs are not just random degradation products but are fully processed (capped and poly-A tailed), explaining their high immunogenicity.
• Clinical Relevance: It provides the first evidence correlating specific subsets of cell-associated HIV RNA (UTR-deficient) with systemic inflammatory markers in patients.

5. Significance

• Rethinking the Reservoir: The findings suggest that "defective" proviruses are not merely dead-end genomic fossils but are biologically active contributors to HIV pathogenesis. They perpetuate inflammation and immune exhaustion even when viral replication is suppressed.
• Therapeutic Implications: Current "Shock and Kill" cure strategies focus on reactivating latent intact proviruses. This study suggests that cure strategies must also address the defective reservoir. Simply eliminating the virus may not be enough; strategies to silence intragenic transcription or block the MDA5 sensing of these RNAs could be necessary to resolve chronic inflammation and comorbidities.
• Aging and Comorbidities: The work offers a molecular explanation for "inflammaging" in PWH, linking the persistence of defective HIV genomes directly to the chronic inflammatory state that accelerates aging and organ damage.

In summary, the paper proposes a model where defective HIV proviruses continuously produce capped, polyadenylated RNAs that are sensed by MDA5 in myeloid cells, triggering a chronic Type I Interferon response and driving the systemic inflammation observed in treated HIV patients.